Supplementary Tables 1 through 3, Supplementary Figures 1 through 7, and Supplementary Methods from Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of &lt;i&gt;BRCA2&lt;/i&gt; Reversion Mutations Associated with Resistance to PARP Inhibitors